Nasdaq · CIK 0001725430
INBS INTELLIGENT BIO SOLUTIONS INC.
Insider trading from SEC Form 4. Last filing Mar 20, 2026.
INTELLIGENT BIO SOLUTIONS INC. (INBS) has 6 SEC Form 4 filings on file from 6 insiders, the latest filed on Mar 20, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
Last 90 days
Signals
Open-market buys and sells at INTELLIGENT BIO SOLUTIONS INC., scored.
Transactions
Every row filed, 8 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 18, 2026 | Steven Constantine Boyages director | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 5,031 | Mar 20, 2026 |
| Mar 18, 2026 | Nicola Marion Fraser director | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 5,000 | Mar 20, 2026 |
| Mar 18, 2026 | Jonathan Scott Hurd director | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 5,006 | Mar 20, 2026 |
| Mar 18, 2026 | Harry Simeonidis Chief Executive Officer | AGrant or award Common Stock | +9,150 | $0.00 | $0 | 13,190 | Mar 20, 2026 |
| Mar 18, 2026 | Jason Isenberg director | AGrant or award Common Stock | +5,000 | $0.00 | $0 | 5,000 | Mar 20, 2026 |
| Mar 18, 2026 | Spiro Kevin Sakiris Chief Financial Officer | AGrant or award Common Stock | +9,150 | $0.00 | $0 | 12,631 | Mar 20, 2026 |
| Mar 18, 2026 | Harry Simeonidis Chief Executive Officer | AGrant or award Common Stock | +21,350 | $0.00 | $0 | 34,540 | Mar 20, 2026 |
| Mar 18, 2026 | Spiro Kevin Sakiris Chief Financial Officer | AGrant or award Common Stock | +21,350 | $0.00 | $0 | 33,981 | Mar 20, 2026 |
Insiders
Everyone who has filed a Form 4 here.
- Steven Constantine Boyagesdirector
- Nicola Marion Fraserdirector
- Jonathan Scott Hurddirector
- Jason Isenbergdirector
- Spiro Kevin SakirisChief Financial Officer
- Harry SimeonidisChief Executive Officer
Questions about INBS
Answered from the filings on this page, as of the latest one.
Are insiders buying INBS?
No. In the last 90 days no insider at INTELLIGENT BIO SOLUTIONS INC. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade INBS on the open market?
No open-market trade has been scored at INTELLIGENT BIO SOLUTIONS INC.. The latest Form 4 on file was filed on Mar 20, 2026 and holds grants, exercises or other rows that are not market trades.
How many insiders file Form 4 at INTELLIGENT BIO SOLUTIONS INC.?
6 people have filed a Form 4 at INTELLIGENT BIO SOLUTIONS INC., among them Steven Constantine Boyages (director), Nicola Marion Fraser (director), Jonathan Scott Hurd (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.